US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 2.2000
  • -0.0400-1.79%
Close Nov 4 16:00 ET
3.15MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.70%-2.25M
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
Net income from continuing operations
32.74%-2.7M
42.79%-4.35M
-191.09%-10.49M
17.75%617K
177.49%513K
-564.90%-4.02M
-165.71%-7.6M
3.43%-3.6M
157.39%524K
24.00%-662K
Operating gains losses
-270.00%-255K
-86.79%116K
23.69%-4.26M
---2.71M
---2.57M
--150K
--878K
---5.58M
----
----
Other non cash items
-82.55%349K
-55.30%582K
782.83%4.68M
--377K
--1M
--2M
--1.3M
--530K
----
----
Change In working capital
105.73%162K
-91.14%340K
-171.08%-290K
-364.06%-911K
-571.08%-391K
-639.79%-2.83M
960.22%3.84M
188.50%408K
179.68%345K
-68.80%83K
-Change in receivables
--0
--0
--0
--13K
--13K
---13K
-114.44%-13K
200.00%90K
--0
--0
-Change in prepaid assets
-63.57%47K
19.67%-49K
333.33%70K
58.12%-49K
-46.32%51K
1,512.50%129K
-281.25%-61K
-600.00%-30K
-50.00%-117K
131.71%95K
-Change in payables and accrued expense
103.91%115K
-90.06%389K
-203.45%-360K
-341.13%-1.11M
-1,700.00%-216K
-654.36%-2.94M
1,258.33%3.91M
192.31%348K
236.28%462K
-104.01%-12K
Cash from discontinued investing activities
Operating cash flow
51.70%-2.25M
-98.35%-3.12M
-24.42%-9.45M
44.26%-2.32M
-60.47%-889K
-394.70%-4.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
Investing cash flow
Cash flow from continuing investing activities
-3M
0
-1M
0
0
0
Net intangibles purchase and sale
----
----
---3M
--0
---1M
----
----
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
----
----
---3M
--0
---1M
----
----
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
3.98M
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
0
3.1M
140.61%10.54M
143.32%10.66M
-119K
Net common stock issuance
--295K
--0
-27.60%7.53M
-62.72%3.87M
--550K
--0
--3.1M
106.05%10.39M
--10.39M
--0
Proceeds from stock option exercised by employees
--4.45M
--4.97M
-99.32%1K
----
----
--0
--0
--148K
----
----
Net other financing activities
---765K
---442K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--3.98M
46.11%4.53M
-28.60%7.53M
-62.98%3.95M
502.52%479K
--0
--3.1M
140.61%10.54M
143.32%10.66M
---119K
Net cash flow
Beginning cash position
-61.22%3.19M
-73.42%1.78M
78.26%6.71M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
20.15%3.76M
-62.91%217K
-20.61%890K
Current changes in cash
125.88%1.73M
-7.66%1.41M
-267.23%-4.93M
-75.01%1.62M
-109.51%-1.41M
-606.79%-6.67M
179.17%1.53M
366.72%2.95M
104.25%6.49M
-25.56%-673K
End cash Position
213.11%4.92M
-61.22%3.19M
-73.42%1.78M
-73.42%1.78M
-25.81%161K
76.52%1.57M
349.32%8.24M
78.26%6.71M
78.26%6.71M
-62.91%217K
Free cash flow
66.20%-2.25M
-98.35%-3.12M
-63.92%-12.45M
44.26%-2.32M
-240.97%-1.89M
-606.79%-6.67M
18.50%-1.57M
-102.56%-7.6M
-246.55%-4.17M
-3.36%-554K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.70%-2.25M-98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K
Net income from continuing operations 32.74%-2.7M42.79%-4.35M-191.09%-10.49M17.75%617K177.49%513K-564.90%-4.02M-165.71%-7.6M3.43%-3.6M157.39%524K24.00%-662K
Operating gains losses -270.00%-255K-86.79%116K23.69%-4.26M---2.71M---2.57M--150K--878K---5.58M--------
Other non cash items -82.55%349K-55.30%582K782.83%4.68M--377K--1M--2M--1.3M--530K--------
Change In working capital 105.73%162K-91.14%340K-171.08%-290K-364.06%-911K-571.08%-391K-639.79%-2.83M960.22%3.84M188.50%408K179.68%345K-68.80%83K
-Change in receivables --0--0--0--13K--13K---13K-114.44%-13K200.00%90K--0--0
-Change in prepaid assets -63.57%47K19.67%-49K333.33%70K58.12%-49K-46.32%51K1,512.50%129K-281.25%-61K-600.00%-30K-50.00%-117K131.71%95K
-Change in payables and accrued expense 103.91%115K-90.06%389K-203.45%-360K-341.13%-1.11M-1,700.00%-216K-654.36%-2.94M1,258.33%3.91M192.31%348K236.28%462K-104.01%-12K
Cash from discontinued investing activities
Operating cash flow 51.70%-2.25M-98.35%-3.12M-24.42%-9.45M44.26%-2.32M-60.47%-889K-394.70%-4.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K
Investing cash flow
Cash flow from continuing investing activities -3M0-1M000
Net intangibles purchase and sale -----------3M--0---1M----------0--0--0
Cash from discontinued investing activities
Investing cash flow -----------3M--0---1M----------0--0--0
Financing cash flow
Cash flow from continuing financing activities 3.98M46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K03.1M140.61%10.54M143.32%10.66M-119K
Net common stock issuance --295K--0-27.60%7.53M-62.72%3.87M--550K--0--3.1M106.05%10.39M--10.39M--0
Proceeds from stock option exercised by employees --4.45M--4.97M-99.32%1K----------0--0--148K--------
Net other financing activities ---765K---442K--------------------------------
Cash from discontinued financing activities
Financing cash flow --3.98M46.11%4.53M-28.60%7.53M-62.98%3.95M502.52%479K--0--3.1M140.61%10.54M143.32%10.66M---119K
Net cash flow
Beginning cash position -61.22%3.19M-73.42%1.78M78.26%6.71M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M20.15%3.76M-62.91%217K-20.61%890K
Current changes in cash 125.88%1.73M-7.66%1.41M-267.23%-4.93M-75.01%1.62M-109.51%-1.41M-606.79%-6.67M179.17%1.53M366.72%2.95M104.25%6.49M-25.56%-673K
End cash Position 213.11%4.92M-61.22%3.19M-73.42%1.78M-73.42%1.78M-25.81%161K76.52%1.57M349.32%8.24M78.26%6.71M78.26%6.71M-62.91%217K
Free cash flow 66.20%-2.25M-98.35%-3.12M-63.92%-12.45M44.26%-2.32M-240.97%-1.89M-606.79%-6.67M18.50%-1.57M-102.56%-7.6M-246.55%-4.17M-3.36%-554K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data